|
1
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statistics, 2024. CA Cancer J Clin. 74:12–49.
2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Witjes JA, Bruins HM, Cathomas R, Compérat
EM, Cowan NC, Gakis G, Hernández V, Linares Espinós E, Lorch A,
Neuzillet Y, et al: European association of urology guidelines on
muscle-invasive and metastatic bladder cancer: Summary of the 2020
guidelines. Eur Urol. 79:82–104. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tran L, Xiao JF, Agarwal N, Duex JE and
Theodorescu D: Advances in bladder cancer biology and therapy. Nat
Rev Cancer. 21:104–121. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu X, Nie L, Zhang Y, Yan Y, Wang C,
Colic M, Olszewski K, Horbath A, Chen X, Lei G, et al: Actin
cytoskeleton vulnerability to disulfide stress mediates
disulfidptosis. Nat Cell Biol. 25:404–414. 2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Meng Y, Chen X and Deng G: Disulfidptosis:
A new form of regulated cell death for cancer treatment. Mol
Biomed. 4(18)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tan YT, Lin JF, Li T, Li JJ, Xu RH and Ju
HQ: LncRNA-mediated posttranslational modifications and
reprogramming of energy metabolism in cancer. Cancer Commun (Lond).
41:109–120. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H,
Wang L, Lu T, Zhang Y, Sun Z and Han X: Machine learning-based
integration develops an immune-derived lncRNA signature for
improving outcomes in colorectal cancer. Nat Commun.
13(816)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liang YL, Zhang Y, Tan XR, Qiao H, Liu SR,
Tang LL, Mao YP, Chen L, Li WF, Zhou GQ, et al: A lncRNA signature
associated with tumor immune heterogeneity predicts distant
metastasis in locoregionally advanced nasopharyngeal carcinoma. Nat
Commun. 13(2996)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Huang Z, Zhou JK, Peng Y, He W and Huang
C: The role of long noncoding RNAs in hepatocellular carcinoma. Mol
Cancer. 19(77)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hutter C and Zenklusen JC: The cancer
genome atlas: Creating lasting value beyond its data. Cell.
173:283–285. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15(550)2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Duforet-Frebourg N, Luu K, Laval G, Bazin
E and Blum MGB: Detecting genomic signatures of natural selection
with principal component analysis: Application to the 1000 genomes
data. Mol Biol Evol. 33:1082–1093. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu L, Xie J, Wu W, Chen H, Li S, He H, Yu
Y, Hu M, Li J, Zheng R, et al: A simple nomogram for predicting
failure of non-invasive respiratory strategies in adults with
COVID-19: A retrospective multicentre study. Lancet Digit Health.
3:e166–e174. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Reimand J, Isserlin R, Voisin V, Kucera M,
Tannus-Lopes C, Rostamianfar A, Wadi L, Meyer M, Wong J, Xu C, et
al: Pathway enrichment analysis and visualization of omics data
using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc.
14:482–517. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mayakonda A, Lin DC, Assenov Y, Plass C
and Koeffler HP: Maftools: Efficient and comprehensive analysis of
somatic variants in cancer. Genome Res. 28:1747–1756.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q,
Li B and Liu XS: TIMER2.0 for analysis of tumor-infiltrating immune
cells. Nucleic Acids Res. 48 (W1):W509–W514. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X,
Li Z, Traugh N, Bu X, Li B, et al: Signatures of T cell dysfunction
and exclusion predict cancer immunotherapy response. Nat Med.
24:1550–1558. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Maeser D, Gruener RF and Huang RS:
oncoPredict: An R package for predicting in vivo or cancer patient
drug response and biomarkers from cell line screening data. Brief
Bioinform. 22(bbab260)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Dobruch J and Oszczudłowski M: Bladder
cancer: Current challenges and future directions. Medicina
(Kaunas). 57(749)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zheng P, Zhou C, Ding Y and Duan S:
Disulfidptosis: A new target for metabolic cancer therapy. J Exp
Clin Cancer Res. 42(103)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Qi C, Ma J, Sun J, Wu X and Ding J: The
role of molecular subtypes and immune infiltration characteristics
based on disulfidptosis-associated genes in lung adenocarcinoma.
Aging (Albany NY). 15:5075–5095. 2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang T, Guo K, Zhang D, Wang H, Yin J, Cui
H and Wu W: Disulfidptosis classification of hepatocellular
carcinoma reveals correlation with clinical prognosis and immune
profile. Int Immunopharmacol. 120(110368)2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Feng Z, Chen R, Huang N and Luo C: Long
non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by
regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid
carcinoma. Life Sci. 244(117298)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jiang Z, Zhang Y, Chen X, Wu P and Chen D:
Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to
inhibit the progression of prostate cancer by upregulating VASH1.
Gene Ther. 27:143–156. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xu J, Huang QY and Ge CJ: Identification
of prognostic long intergenic non-coding RNAs as competing
endogenous RNAs with KRAS mutations in colorectal cancer. Oncol
Lett. 22(717)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kar S: Unraveling cell-cycle dynamics in
cancer. Cell Syst. 2:8–10. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lin X, Zhuang S, Chen X, Du J, Zhong L,
Ding J, Wang L, Yi J, Hu G, Tang G, et al: lncRNA ITGB8-AS1
functions as a ceRNA to promote colorectal cancer growth and
migration through integrin-mediated focal adhesion signaling. Mol
Ther. 30:688–702. 2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li Y, Kong Y, An M, Luo Y, Zheng H, Lin Y,
Chen J, Yang J, Liu L, Luo B, et al: ZEB1-mediated biogenesis of
circNIPBL sustains the metastasis of bladder cancer via
Wnt/β-catenin pathway. J Exp Clin Cancer Res.
42(191)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Valero C, Lee M, Hoen D, Wang J, Nadeem Z,
Patel N, Postow MA, Shoushtari AN, Plitas G, Balachandran VP, et
al: The association between tumor mutational burden and prognosis
is dependent on treatment context. Nat Genet. 53:11–15.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
McGrail DJ, Pilié PG, Rashid NU, Voorwerk
L, Slagter M, Kok M, Jonasch E, Khasraw M, Heimberger AB, Lim B, et
al: High tumor mutation burden fails to predict immune checkpoint
blockade response across all cancer types. Ann Oncol. 32:661–672.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lyu Q, Lin A, Cao M, Xu A, Luo P and Zhang
J: Alterations in TP53 are a potential biomarker of bladder cancer
patients who benefit from immune checkpoint inhibition. Cancer
Control. 27(1073274820976665)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhou Z, Zhou Y, Liu W and Dai J: A novel
cuproptosis-related lncRNAs signature predicts prognostic and
immune of bladder urothelial carcinoma. Front Genet.
14(1148430)2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Conde M and Frew IJ: Therapeutic
significance of ARID1A mutation in bladder cancer. Neoplasia.
31(100814)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhao Z, Aoi Y, Philips CN, Meghani KA,
Gold SR, Yu Y, John LS, Qian J, Zeidner JM, Meeks JJ and
Shilatifard A: Somatic mutations of MLL4/COMPASS induce cytoplasmic
localization providing molecular insight into cancer prognosis and
treatment. Proc Natl Acad Sci USA. 120(e2310063120)2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46.
2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liang T, Tao T, Wu K, Liu L, Xu W, Zhou D,
Fang H, Ding Q, Huang G and Wu S: Cancer-associated
fibroblast-induced remodeling of tumor microenvironment in
recurrent bladder cancer. Adv Sci (Weinh).
10(e2303230)2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Noyes D, Bag A, Oseni S, Semidey-Hurtado
J, Cen L, Sarnaik AA, Sondak VK and Adeegbe D: Tumor-associated
Tregs obstruct antitumor immunity by promoting T cell dysfunction
and restricting clonal diversity in tumor-infiltrating CD8+ T
cells. J Immunother Cancer. 10(e004605)2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yang MW, Tao LY, Jiang YS, Yang JY, Huo
YM, Liu DJ, Li J, Fu XL, He R, Lin C, et al: Perineural invasion
reprograms the immune microenvironment through cholinergic
signaling in pancreatic ductal adenocarcinoma. Cancer Res.
80:1991–2003. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Meeks JJ and Lerner SP: Molecular
landscape of non-muscle invasive bladder cancer. Cancer Cell.
32:550–551. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Carneiro BA and El-Deiry WS: Targeting
apoptosis in cancer therapy. Nat Rev Clin Oncol. 17:395–417.
2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sun Z, Wang J, Fan Z, Yang Y, Meng X, Ma
Z, Niu J, Guo R, Tran LJ, Zhang J, et al: Investigating the
prognostic role of lncRNAs associated with disulfidptosis-related
genes in clear cell renal cell carcinoma. J Gene Med.
26(e3608)2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lu H, Wu J, Liang L, Wang X and Cai H:
Identifying a novel defined pyroptosis-associated long noncoding
RNA signature contributes to predicting prognosis and tumor
microenvironment of bladder cancer. Front Immunol.
13(803355)2022.PubMed/NCBI View Article : Google Scholar
|
